Vascular endothelial growth factor (VEGF) receptor-2 signaling mediates VEGF-C(deltaNdeltaC)- and VEGF-A-induced angiogenesis in vitro (Q28567645)

Jonathan P Sleeman

8

0 references

Kari Alitalo

Kari Alitalo

10

0 references

Michael S Pepper

Michael S Pepper

11

0 references

Daniel J. Hicklin

7

Daniel J. Hicklin

1 reference

31 January 2017

7

Daniel J Hicklin

0 references

Napoleone Ferrara

5

Napoleone Ferrara

1 reference

31 January 2017

Jean-Christophe Tille

1

Jean-Christophe Tille

1 reference

31 January 2017

Xueyan Wang

2

1 reference

31 January 2017

Kenneth E. Lipson

3

1 reference

31 January 2017

Gerald McMahon

4

1 reference

31 January 2017

Zhenping Zhu

6

1 reference

31 January 2017

Jonathan P. Sleeman

8

1 reference

31 January 2017

Ulf Eriksson

9

1 reference

31 January 2017

Kari Alitalo

10

1 reference

31 January 2017

Michael S. Pepper

Experimental Cell Research

11

1 reference

31 January 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

31 January 2017

May 2003

0 references

published in

1 reference

31 January 2017

285

1 reference

31 January 2017

2

1 reference

31 January 2017

286–298

1 reference

31 January 2017

286-298

0 references

cites work

Mechanisms of angiogenesis and arteriogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Role of vascular endothelial growth factor in regulation of physiological angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular growth factors and lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor C induces angiogenesis in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Transforming growth factor beta 1 down-regulates vascular endothelial growth factor receptor 2/flk-1 expression in vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Cultured endothelial cell monolayers that restrict the transendothelial passage of macromolecules and electrical current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Coupling and connexin 43 expression in microvascular and large vessel endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Tumor-promoting phorbol esters induce angiogenesis in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

SU5416 and SU5614 inhibit kinase activity of wild-type and mutant FLT3 receptor tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor induces cyclooxygenase-dependent proliferation of endothelial cells via the VEGF-2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor KDR receptor signaling potentiates tumor necrosis factor-induced tissue factor expression in endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor governs endothelial nitric-oxide synthase expression via a KDR/Flk-1 receptor and a protein kinase C signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial growth factor effect on endothelial cell proliferation, migration, and platelet-activating factor synthesis is Flk-1-dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

KDR activation is crucial for VEGF165-mediated Ca2+ mobilization in human umbilical vein endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Lymphatic endothelium: a new frontier of metastasis research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Vascular endothelial cell growth factor-driven endothelial tube formation is mediated by vascular endothelial cell growth factor receptor-2, a kinase insert domain-containing receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Relative effects of VEGF-A and VEGF-C on endothelial cell proliferation, migration and PAF synthesis: Role of neuropilin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

A model for gene therapy of human hereditary lymphedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3

The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4827%2803%2900053-3